In and around magtivio markets
Magtivio and its distributor Premedical Lab from Beijing, China will be exhibiting magtivio’s extraction products at the 20th edition of the China Association of Clinical Laboratory Practice Expo (CACLP) in the Nanchang Greenland International Expo Center, from 28-30 May 2023.
We will have joint booth in Hall A5 – 3321. You can discuss any sample preparation needs with our Distribution Channel Manager Freek Gubbels.
We are exhibiting our magnetic sample preparation solutions for Plant and Animal Genomics at PAG 30 in San Diego from January 15 – 17.
Meet Peter van Driessche and Kevin Custers at booth 621 to discuss your sample preparation needs.
We will be exhibiting our magnetic sample preparation solutions at Medica in Düsseldorf from November 14 – 17.
Meet us in Hall 1 – booth C33 to discuss your sample preparation needs.
Our Sales Team Leader Peter van Driessche and our Distribution Channel Manager Freek Gubbels will be present at the 6th Congress of the European Association of Veterinary Diagnosticians (EAVLD) in Sevilla (ES) from October 24 – 26.
Meet up with them at tabletop #T5 to discuss your veterinary sample preparation needs.
Our Sales Team Leader Peter van Driessche and our Distribution Channel Manager Freek Gubbels will be present at the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo in Chicago from July 24- 28.
Meet up with them at booth #4742 to discuss your sample preparation needs.
MagSi-DX Pathogen declared to meet IVDR
The In Vitro Diagnostics Regulation (IVDR) is the new regulatory framework which will affect all in vitro diagnostic medical devices on the European market. The IVDR (Regulation (EU) 2017/746) replaces the EU Directive on in vitro diagnostic devices (IVDD 98/79/EC) and will apply from 26 May 2022 onward.
Our product MagSi-DX Pathogen (to be used for the isolation and purification of viral RNA for subsequent in-vitro diagnostic purposes) has been declared to meet the IVDR requirements and, subsequently, has been registered at the official government body.
We will continue marketing MagSi-DX Pathogen and other clinical diagnostic extraction products, compliant with the new regulations.
We congratulate everyone in and outside of magtivio who made this IVDR compliance possible.
